Integration of DNA into bacterial chromosomes from plasmids without a counter-selection marker by Heap, John T. et al.
Integration of DNA into bacterial chromosomes
from plasmids without a counter-selection marker
John T. Heap, Muhammad Ehsaan, Clare M. Cooksley, Yen-Kuan Ng,
Stephen T. Cartman, Klaus Winzer and Nigel P. Minton*
Clostridia Research Group, BBSRC Sustainable BioEnergy Centre, School of Molecular Medical Sciences,
Centre for Biomolecular Sciences, The University of Nottingham, University Park, Nottingham NG7 2RD, UK
Received January 18, 2011; Revised November 24, 2011; Accepted December 23, 2011
ABSTRACT
Most bacteria can only be transformed with circular
plasmids, so robust DNA integration methods for
these rely upon selection of single-crossover
clones followed by counter-selection of double-
crossover clones. To overcome the limited availabil-
ity of heterologous counter-selection markers, here
we explore novel DNA integration strategies that do
not employ them, and instead exploit (i) activation or
inactivation of genes leading to a selectable pheno-
type, and (ii) asymmetrical regions of homology to
control the order of recombination events. We focus
here on the industrial biofuel-producing bacterium
Clostridium acetobutylicum, which previously
lacked robust integration tools, but the approach
we have developed is broadly applicable. Large se-
quences can be delivered in a series of steps, as we
demonstrate by inserting the chromosome of phage
lambda (minus a region apparently unstable in
Escherichia coli in our cloning context) into the
chromosome of C. acetobutylicum in three steps.
This work should open the way to reliable integra-
tion of DNA including large synthetic constructs in
diverse microorganisms.
INTRODUCTION
The addition of DNA conferring new or altered properties
to microorganisms has underpinned biotechnology for
decades. Recently, the potential scope and scale of this
approach has grown with the acceleration of genome
sequencing, development of commercial de novo DNA
synthesis and advent of Synthetic Biology, the new discip-
line which brings engineering principles to the design and
construction of biological systems (1).
DNA can be added to microorganisms using replicative
plasmids, but these are inherently unstable, limiting their
applied utility. To stabilize exogenous DNA, it must be
irreversibly incorporated into a stable DNA molecule
inside the cell, usually a chromosome. This can be accom-
plished in a one-step homologous recombination proced-
ure (often called ‘allele exchange’ or ‘gene replacement’)
for those organisms that are efﬁciently transformed with
linear DNA, such as yeast and naturally competent
bacteria like Bacillus subtilis (2). A selectable marker
gene positioned alongside the DNA sequence of interest
within an allele exchange cassette is only retained by the
desired recombinant cells, allowing these cells to be spe-
ciﬁcally selected and easily isolated, typically using an
antibiotic. Large or multiple sequences can be inserted at
a single locus simply by alternating between two selectable
markers in a series of integration steps, as in the ‘domino’
method of Itaya et al. (3).
Most bacteria cannot be transformed with linear DNA,
so an integrative plasmid bearing the homologous recom-
bination construct is used instead. As plasmids are
circular, a single homologous recombination event can re-
versibly integrate the entire plasmid into the chromosome,
resulting in unstable single-crossover cells with the poten-
tial to revert to wild-type. The desired stable double-
crossover cells are much rarer, as they result from two
homologous recombination events in a single cell or
lineage. Double-crossover cells are not easily isolated
from single-crossover cells, because both contain the se-
lectable marker in the cassette. This issue can be overcome
using a counter-selection marker located on the plasmid
‘backbone’, but identifying a suitable counter-selection
marker and appropriate conditions for its use can be
one of the most challenging aspects of developing
genetic tools for a particular organism (4). We are inter-
ested in several bacterial species for which genetic tools are
very limited, and the use of counter-selection markers has
not been described.
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selection of double-crossover clones at certain types of
genomic loci without using a plasmid-borne counter-
selection marker. Crucially, the expression of a selectable
marker gene is coupled to the formation of the desired
double-crossover recombinant chromosome, so that
double-crossover clones can be isolated using the
associated selectable phenotype. We call this approach
allele-coupled exchange (ACE). The principles described
here bring much of the power and practical simplicity of
linear DNA procedures to integration of plasmid-
borne DNA, and open the way to the step-by-step inser-
tion of large DNA sequences into diverse microbial
chromosomes, as we demonstrate using Clostridium
acetobutylicum.
MATERIALS AND METHODS
Bacterial strains
Escherichia coli strains were grown in Luria-Bertani (LB)
broth at 37 C with rotary shaking at 200 rpm, or on LB
plates. All solid media were prepared by adding 1.5 % w/v
agar to the corresponding broth. E. coli strains containing
plasmids (Table 1) were cultured in LB broth supple-
mented with 12.5mg/ml chloramphenicol, or on LB
plates supplemented with 25mg/ml chloramphenicol.
E. coli strain TOP10 (Invitrogen) was used for plasmid
cloning and storage, strain CA434 (5) was used as a con-
jugation donor, and TOP10 containing pAN2 (6) was used
for in vivo methylation of plasmid DNA prior to trans-
formation of C. acetobutylicum. Clostridium spp. were
grown in static culture at 37 C under an anaerobic atmos-
phere of N2:H2:CO2 (80:10:10, vol:vol:vol) in an anaerobic
workstation (Don Whitley, UK) using media prereduced
overnight under the same conditions. Plasmids were
transferred into Clostridium spp. by electroporation or
conjugation as described previously (7).
Plasmid construction
Integration vectors for use in C. acetobutylicum ATCC
824, Clostridium sporogenes NCIMB 10696 and
Clostridium difﬁcile 630 are based upon Clostridium–E.
coli shuttle plasmids pMTL85141, pMTL85151 and
pMTL83151, respectively (7), and differ to those
parental plasmids only between the SbfI and AscI sites.
The integration vectors and their key functional compo-
nents are listed in Table 1, and annotated sequences are
available from GenBank/EMBL/DDJB. Chromosomal
DNA of phage lambda cI857ind 1 Sam 7 was obtained
from NEB and fragments were cloned as shown in
Figure 3. L12 was derived from L18 by a spontaneous
deletion of 5996 bp corresponding to nucleotides 21738–
27733 of the lambda cI857ind 1 Sam 7 chromosome.
Growth media for integration procedures in
Clostridium acetobutylicum
After electroporation, transformants of C. acetobutylicum
were selected on CGM (8) agar plates supplemented with
15mg/ml thiamphenicol to select for the plasmid-borne
resistance marker catP and 20mg/ml uracil to allow
pyrE mutants to grow (except for those experiments
which did not involve pyrE mutants, where uracil
was not required). CGM agar plates supplemented
with 400mg/ml 5-ﬂuoroorotic acid (FOA) and 1mg/ml
uracil were used to select pyrE-minus clones. These
conditions were validated using a previously constructed
pyrF mutant (6) which should have the same phenotype
as a pyrE mutant. CBM (9) agar plates (which do not
contain uracil) were used to select clones able to synthe-
sise their own uracil, which requires a functional
pyrE gene. Erythromycin-resistant clones were selected
on CGM agar plates supplemented with 40mg/ml
erythromycin.
PCR analysis of chromosomal insertions
Genomic DNA from Clostridium spp. was prepared
using the QIAGEN DNeasy Blood and Tissue Kit in
accordance with the manufacturer’s instructions and rec-
ommended pretreatment for Gram-positive bacteria.
PCRs were performed using Taq DNA polymerase
(NEB) or KOD DNA Polymerase (Merck) or Phusion
polymerase (NEB) in accordance with the manufactur-
er’s instructions. Appropriate combinations of oligo-
nucleotide primers are speciﬁed in the legends of
relevant ﬁgures and in the Supplementary Data, and
oligonucleotide sequences are listed in Supplementary
Table S1.
Analysis of fermentation products
The fermentation products of wild-type C. acetobutylicum
ATCC 824 were compared to the adh-expressing recom-
binant strain in batch culture using CBM broth containing
50g/l glucose and 5g/l CaCO3. Starter cultures in the
same medium were inoculated using fresh colonies, then
when these reached an OD600 of  0.5, they were used at a
1% inoculum to start the main cultures. Samples of 1ml
were removed, placed on ice, then centrifuged at 16000g
for 1.5min. Supernatants were removed and stored at
 20 C before analysis by gas chromatography. Ethanol,
acetone, butanol, acetic acid and butyric acid were
quantiﬁed using a Thermo Focus GC equipped with a
30m TR-FFAP column (0.25mm internal diameter)
and a ﬂame ionization detector. H2 was used as the
carrier gas at 0.8ml/min. The ﬂame was maintained by
35ml/min H2, 350ml/min compressed air and 30ml/min
N2. The injector and detector temperatures were 240 C
and 270 C, respectively. Peaks were resolved using a
column proﬁle of 40 C for 2min, followed by a 30 C/
min ramp to 140 C, then a 45 C/min ramp to 210 C
and ﬁnally 1min at 210 C. Samples were extracted
before injection by adding an equal volume of ethyl
acetate (500ml) to the supernatant sample, vortexing for
10s and centrifuging for 5min at 16000g. The 300ml
organic phase was removed to a 2ml sample vial contain-
ing a 300ml deactivated glass insert. Samples of 1ml were
injected.
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Speciﬁc selection of double-crossovers by switching
the state of pyrE
Clostridium acetobutylicum is an industrial organism
that naturally produces the excellent biofuel butanol, but
the yield, speciﬁcity and feedstock utilization of the
fermentation process might each be improved by the
addition of DNA encoding heterologous enzymes (10).
This motivated us to develop a robust DNA integration
method for C. acetobutylicum. Our ﬁrst approach requires
a gene which is both positively and negatively selectable,
such as pyrE or pyrF, which encode the pyrimidine bio-
synthesis enzymes orotate phosphoribosyltransferase and
orotidine 5-phosphate decarboxylase, respectively. Cells
which contain pyrE and pyrF can be selected on growth
medium lacking uracil, as they are required for uracil bio-
synthesis. Conversely, cells that lack either pyrE or pyrF
can be selected on growth medium supplemented with
FOA, as this compound is highly toxic only to cells
which contain this pathway. FOA has been used for coun-
ter selection for some time (11) and in various organisms
(12–17) including very recently in Clostridium
thermocellum (18).
To isolate double-crossover clones by exploiting a
change in the state of pyrE, we designed a special allele
exchange cassette (Figure 1A). The two regions of
homology are of very different lengths, in an attempt to
control the order of the recombination events. A long
region of homology corresponding to the 1200bp imme-
diately downstream of pyrE is intended to direct the ﬁrst
recombination event so that a large majority of
single-crossover clones are the result of recombination in
this region, which would not inactivate pyrE. A subse-
quent recombination event at a second, much smaller
region of homology corresponding to a 300bp internal
portion of pyrE would excise the plasmid, resulting in
FOA-resistant (FOA
R) double-crossover cells in which
Figure 1. DNA integration at the pyrE locus of C. acetobutylicum.
(A) Selection of stable double-crossover clones using pMTL-JH12.
The ﬁrst recombination event (plasmid integration) is mediated by
the long region of homology between pMTL-JH12 and hydA.
Single-crossover clones are obtained on medium containing
thiamphenicol. The second recombination event (plasmid excision) is
mediated by the short region of homology between pMTL-JH12 and
an internal portion of pyrE. Double-crossover clones are selected using
FOA. (B) PCR screening of eight candidate single-crossover clones
using primers lacZa-sF2 and Cac-hydA-sR2, which anneal to the
single-crossover chromosome where indicated in (A). MW, 2-Log
DNA Ladder (NEB) molecular weight marker; plasmid, pMTL-JH12
plasmid DNA control; WT, wild-type C. acetobutylicum genomic DNA
Figure 1. Continued
control; 1–8, candidate clones. All eight candidates show the expected
1428 bp band. (C) PCR screening of eight candidate double-crossover
clones using primers CAC0026-sF2 and M13F which anneal to the
double-crossover chromosome where indicated in (A). MW, 2-Log
DNA Ladder (NEB) molecular weight marker; plasmid, pMTL-JH12
plasmid DNA control; WT, wild-type C. acetobutylicum genomic DNA
control; 1–8, candidate clones. All eight candidates show the expected
558bp band. (D) Selection of stable double-crossover clones using
pMTL-JH14. The ﬁrst recombination event (plasmid integration) is
mediated by the long region of homology between pMTL-JH14 and
hydA/lacZ. Single-crossover clones are obtained on medium containing
thiamphenicol. The second recombination event (plasmid excision) is
mediated by the short region of homology between pMTL-JH14 and
the corresponding portion of pyrE. Double-crossover clones are
selected using growth medium lacking uracil. (E) PCR screening of
seven candidate double-crossover clones using primers CAC0026-sF2
and M13F which anneal to the double-crossover chromosome where
indicated in (C). MW, 2-Log DNA Ladder (NEB) molecular weight
marker; plasmid, pMTL-JH14 plasmid DNA control; 1–7, candidate
clones. Controls using DNA from two of the pyrE-minus clones
obtained in (A) are marked as parent clones. All seven candidates
show the expected 861bp band, and the parent clones show the
expected 558 bp band. This increase of 303 bp corresponds to the res-
toration of the truncated pyrE gene to full length.
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delivered to the chromosome.
We constructed plasmid pMTL-JH12 (Figure 1A),
which includes the allele exchange cassette described
above, the chloramphenicol/thiamphenicol-resistance
marker catP and the origin of replication from Bacillus
plasmid pIM13 (19). Like several other Clostridia and
many other organisms, C. acetobutylicum is not efﬁciently
transformed by electroporation, so it is not generally
practical to use suicide plasmids (that is, typically no
colonies appear on selective plates following electropor-
ation of suicide plasmids). Instead, replicative plasmids
are used, so transformants are readily obtained. The
pIM13 replicon exhibits segregational instability in
C. acetobutylicum (7), and single-crossover clones which
spontaneously arise within transformant populations can
be isolated by subculture under antibiotic selection.
Clostridium acetobutylicum cells were transformed with
pMTL-JH12 DNA and plated onto medium supple-
mented with thiamphenicol and uracil. Typically, 10–100
colonies were visible after 24–48 h incubation, and two
clones from each of four independent transformations
were subcultured twice on the same medium. The eight
resulting clones were screened by PCR, and all were
shown to be single-crossover clones in which pMTL-
JH12 had integrated into the chromosome via homolo-
gous recombination at the long region of homology, as
intended (Figure 1B). Next, the eight single-crossover
clones were subcultured onto medium supplemented
with FOA and uracil to select the desired pyrE-minus
double-crossover clones. FOA
R colonies were obtained
from each of the eight independent subcultures, and
one clone from each was puriﬁed by subculturing
again on the same medium. PCR screening showed the
expected double-crossover genotype for all eight clones
(Figure 1C), and replica-plating on medium with and
without thiamphenicol conﬁrmed the absence of the
plasmid-borne catP marker.
The strategy described above effectively replaces a nega-
tively selectable gene with a sequence of interest, which
could be achieved using a conventional allele exchange
cassette (14). The crucial difference is that the pyrE
locus of a recombinant strain constructed using pMTL-
JH12 is specially conﬁgured to facilitate subsequent
genetic modiﬁcation (Figure 1D). The non-functional
pyrE gene in these cells is not completely deleted, it is
only truncated at the 30-end. Homologous recombination
between this partial pyrE gene and an appropriate coun-
terpart partial pyrE gene, foreshortened at the 50-end,
would result in a full-length, functional gene. We con-
structed plasmid pMTL-JH14, which is almost identical
to pMTL-JH12, except the 300bp internal portion of
pyrE that comprises the small homology region is
followed immediately by the remainder of the pyrE
coding sequence (Figure 1D). As before, the long region
of homology is intended to direct plasmid integration,
without affecting the pyrE phenotype. Subsequent
plasmid excision via the short 300-bp homology region
will result in the desired double-crossover clones, speciﬁc-
ally selectable by their pyrE-positive, uracil prototrophic
phenotype. We transformed one of the previously
constructed pyrE mutant clones of C. acetobutylicum
with pMTL-JH14 DNA, selected transformants on
plates supplemented with thiamphenicol and uracil and
subcultured them twice on this medium. To select pyrE-
positive clones, cells were subcultured onto medium
lacking uracil. Seven independent clones were puriﬁed
and shown to be the intended double-crossovers by PCR
(Figure 2D) and thiamphenicol sensitivity.
It would be useful to apply the strategy above to
Clostridium spp. other than C. acetobutylicum. We con-
structed plasmids equivalent to pMTL-JH12 and pMTL-
JH14 for C. sporogenes NCIMB 10696, which shows
potential in novel tumor therapies (20); and strain
630erm of the important human pathogen C. difﬁcile
(21) (Table 1). Double-crossover clones of both these or-
ganisms could be selected using media supplemented with
FOA, as described in the Supplementary Data and shown
in Supplementary Figure S2. Integration at the pyrF locus
of C. acetobutylicum, including insertions of fragments of
phage lambda DNA of various sizes, is also described in
the Supplementary Data and shown in Supplementary
Figure S1.
Coupling expression of heterologous selectable markers
to a chromosomal promoter
Using plasmid pMTL-JH14 in the specially conﬁgured
pyrE mutant constructed using pMTL-JH12, we had
effectively fused together two partial pyrE genes to result
in one complete, functional pyrE gene via recombination
in the middle of the coding sequence. We realized that a
recombination event bringing together two partial genes
to form one whole gene need not occur in the coding
sequence. In an alternative arrangement, the full-length
coding sequence of a selectable marker, lacking only a
promoter, could be linked by recombination to a
promoter situated on the chromosome, completing the
gene and leading to its expression. We designed plasmid
pMTL-JH31 (Figure 2A) to implement this modiﬁed
concept by integrating a pyrE gene lacking its own
promoter into the chromosome of the previously con-
structed pyrE mutant of C. acetobutylicum. The insertion
was targeted to a site downstream of the thiolase (thl)
promoter, which is known to exhibit strong expression
throughout growth (22,23). To prevent possible hom-
ologous recombination at the pyrE locus, pMTL-JH31
uses the orthologous pyrE gene from C. sporogenes
ATCC 15579, which is only 47.6% identical to the
C. acetobutylicum gene. As before, a long (1200 bp)
region of homology directs plasmid integration without
altering the pyrE phenotype, and single-crossover clones
are obtained on medium containing thiamphenicol.
Subsequently, plasmid excision mediated by a second
region of homology places the silent (non-expressed)
pyrE gene immediately downstream of the thl gene on
the chromosome, leading to its co-expression with thl,
and allowing these double-crossover clones to be selected
on medium lacking uracil (Figure 2A). To test this scheme,
we transformed the pyrE mutant of C. acetobutylicum
with pMTL-JH31 DNA, and performed the integra-
tion procedure as described above for pMTL-JH14.
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(Figure 2B) and thiamphenicol sensitivity, and all were
veriﬁed, conﬁrming the utility of this modiﬁed approach.
The use of recombination to link a chromosomal
promoter to a selectable marker within an allele
exchange cassette represents a very ﬂexible strategy, not
limited to restoration of an auxotrophic mutant to
prototrophy. We constructed pMTL-JH16, which is iden-
tical to pMTL-JH31, except the ribosome-binding site and
coding sequence of pyrE are replaced by those of the
macrolide–lincosamide–streptogramin (MLS) antibiotic-
resistance marker ermB (24). As before a long (1200 bp)
region of homology directs plasmid integration. Next, the
recombination event mediating plasmid excision positions
ermB immediately downstream of thl, leading to ermB
expression and an MLS-resistant phenotype which can
be used to speciﬁcally select double-crossover clones
(Figure 2C). We tested pMTL-JH16 in wild-type
C. acetobutylicum using a similar integration procedure
as before, culturing transformants initially on
thiamphenicol, and were readily able to speciﬁcally select
double-crossover clones using the macrolide antibiotic
erythromycin. Six recombinant clones were screened in
the same way as before, and all were conﬁrmed to be
the desired recombinants (data not shown).
Integration and expression of an alcohol dehydrogenase
In the previous strategy, the expression of heterologous
marker genes was coupled to the formation of a recom-
binant double-crossover chromosome, providing a means
to select these clones. Next we sought to extend this
principle to the expression of other heterologous genes
of interest, for other purposes. Besides butanol, the
other major products of sugar fermentation by
C. acetobutylicum are acetone and ethanol, and the
process is often called the acetone–butanol–ethanol
(ABE) fermentation (25). Butanol is the most valuable
product, but ethanol also has value both as a commodity
chemical and as a biofuel. Acetone is less valuable and
is not suitable as a fuel, so it represents an undesirable
by-product or waste product of the industrial ABE
process. Clostridium beijerinckii NRRL B593 has a
similar physiology to C. acetobutylicum, but reduces
Figure 2. DNA integration at the thl locus of C. acetobutylicum.
(A) Selection of stable double-crossover clones using pMTL-JH31.
The ﬁrst recombination event (plasmid integration) is mediated by
the long region of homology between pMTL-JH31 and CAC2872/
atpB. Single-crossover clones are obtained on medium containing
thiamphenicol. The second recombination event (plasmid excision) is
mediated by the short region of homology between pMTL-JH31 and
the 30-end of thl. Double-crossover clones are selected using growth
medium lacking uracil. (B) PCR screening of ﬁve candidate
double-crossover clones using primers Cac-thl-sF1 and M13F which
anneal where indicated in (A). MW, 2-Log DNA Ladder (NEB) mo-
lecular weight marker; plasmid, pMTL-JH31 plasmid DNA control;
WT, wild-type C. acetobutylicum genomic DNA control; 1–5, candidate
clones. All ﬁve candidates show the expected 1101 bp band.
(C) Selection of stable double-crossover clones using pMTL-JH16
Figure 2. Continued
containing adh. The ﬁrst recombination event (plasmid integration) is
mediated by the long region of homology between pMTL-JH16 and
CAC2872/atpB. Single-crossover clones are obtained on medium con-
taining thiamphenicol. The second recombination event (plasmid
excision) is mediated by the short region of homology between
pMTL-JH16 and the 30-end of thl. Double-crossover clones are
selected using erythromycin. (D) PCR screening of one candidate
adh-expressing double-crossover clone using primers Cac-thl-sF1 and
Cac-atpB-sR1 which anneal where indicated in (C). MW, 2-Log
DNA Ladder (NEB) molecular weight marker; WT, wild-type
C. acetobutylicum genomic DNA control which shows the expected
1660 bp band; adh, candidate clone which shows the expected 3523bp
band. (E) Concentrations of acetone and isopropanol in the supernatant
of cultures of wild-type C. acetobutylicum (WT) or the adh-expressing
recombinant clone after 72 h growth. The concentrations of both fermen-
tation products differ signiﬁcantly between the two strains (P < 0.01).
e59 Nucleic Acids Research, 2012,Vol. 40,No. 8 PAGE 6 OF 10the acetone it produces to isopropanol (propan-2-ol) using
an NADPH-dependent primary/secondary alcohol de-
hydrogenase (26). Isopropanol is more valuable than
acetone, and could be used as biofuel in a blend with
butanol and ethanol, so it would be useful to add the
adh gene which encodes this activity to C. acetobutylicum.
We inserted the coding sequence of adh into
pMTL-JH16 along with a ribosome-binding site, but did
not provide a promoter (Figure 2C). Double-crossover
recombinants will therefore contain an artiﬁcial
thl-ermB-adh operon, with all three genes dependent
upon the thl promoter for expression. The integration pro-
cedure was performed as before, and double-crossover
clones were selected using erythromycin. We picked only
one clone of the many obtained to screen for integration
of adh, because the experiments described in the previous
sections suggested that screening multiple clones was un-
necessary. The adh-containing clone was veriﬁed as before
by PCR (Figure 2D) and thiamphenicol sensitivity. We
compared the fermentation products of the adh-containing
clone to the wild-type using anaerobic batch cultivation
conditions under which C. acetobutylicum exhibits classic
bi-phasic growth, switching from organic acid production
to acid re-uptake and solvent production as it enters
stationary phase. After 72h growth, supernatants of
wild-type cultures contained typical concentrations of
fermentation products, including 91.9±8.4mM butanol,
52.9±4.7mM acetone and 12.6±1.5mM ethanol.
At the same timepoint, supernatants from cultures of
the adh clone contained 15.4±3.1mM acetone and
27.9±6.7mM isopropanol (Figure 2E). None of the
other fermentation product concentrations differed signiﬁ-
cantly from the wild-type. This result demonstrates ex-
pression of functional adh, and the recombinant strain
represents an improvement over the wild-type from an
industrial perspective.
Multistep integration of the phage lambda genome
Up to 1.8kb of heterologous DNA was integrated in the
experiments described above, and larger fragments of
up to 6.5kb were integrated in additional experiments
described in the Supplementary Data. However, there
must be limits to the size of DNA that can be delivered
in a single step. For C. acetobutylicum, this limitation may
well be imposed by the frequency of transformation,
which is low even for small plasmids (7). Sequences too
large to be integrated in a single step could be delivered in
a series of steps using overlapping subfragments of the
desired sequence, as in the domino method for Bacillus
subtilis (3). This might be achieved either by alternately
switching on and off a positively and negatively selectable
gene such as pyrE (Figure 1) or by alternately linking ex-
pression of two different heterologous selectable markers
to a chromosomal promoter (Figure 2). In either scheme,
the short region of homology would remain the same in
every step, whereas the long region of homology would
target the end of the previous insert in the second and
subsequent steps.
To test multistep DNA delivery using ACE, we at-
tempted to insert the entire genome of phage lambda
into the chromosome of C. acetobutylicum. We identiﬁed
three restriction fragments of circular phage lambda DNA
(circularized by ligation of the cohesive ends of the linear
chromosome) that covered the entire genome and
provided regions of overlap suitable to direct the initial
recombination events in the second and third ACE steps
(Figure 3). We used restriction ligation cloning to insert
the 28kb fragment (L28), 18 kb fragment (L18) and
6.5kb fragment (L6.5) into ACE vectors pMTL-JH16,
pMTL-JH30 and pMTL-JH15, respectively. Vectors
pMTL-JH30 and pMTL-JH15 are similar to pMTL-
JH31 and pMTL-JH16, but do not include a long region
of homology, so these vectors are appropriate when the
long region of homology depends upon a previous step,
and must therefore be provided with the insert or as part
of the insert (Table 1). When we inserted L18 into
pMTL-JH30, we obtained clones with deletions in the
lambda sequence. It appears that cloning this region
(which includes lysis genes) into pMTL-JH30 is toxic to
E. coli, so clones with spontaneous deletions are selected.
In one of these constructs, 6kb of DNA is deleted, but the
regions required for recombination between fragments are
not affected. We used this 12 kb of lambda DNA (L12)
instead of L18, and proceeded to the multistep integration.
We integrated each of the three lambda DNA fragments
in turn into the chromosome of the pyrE mutant of
C. acetobutylicum (Figure 3). Double-crossover clones
were selected using erythromycin (ermB+) for the L28 in-
sertion, then medium lacking uracil (pyrE+) for the L12
insertion, then erythromycin again for the L6.5 insertion.
At each step, the insertion was initially veriﬁed by
thiamphenicol sensitivity and PCR. After all three inser-
tions were completed, a Southern blot of EcoRI-digested
genomic DNA from the three recombinant strains (con-
taining one, two or three lambda DNA insertions) was
performed, using lambda DNA as the probe (Figure
3D). EcoRI-digested genomic DNA from the parental
pyrE mutant strain was also included, as was
EcoRI-digested plasmid DNA of the three integration
plasmids. All samples showed the expected distinguishing
pattern of fragments (none in the case of the pyrE strain
control) conﬁrming the successful multistep insertion. The
insertions were also veriﬁed by sequencing.
DISCUSSION
In this work, we addressed the need to reliably and stably
deliver DNA to organisms lacking mature genetic tools,
which include bacterial species of applied importance. The
specialized allele exchange approaches we have
demonstrated share two common principles: (i) cells in
which a particular homologous recombination event has
occurred can be selected if the event interrupts a
counter-selectable gene, or appropriately fuses together
two parts of a positively-selectable gene; and (ii) regions
of homology of very different lengths strongly bias the
order of homologous recombination events, and can
therefore be exploited to couple acquisition of a selectable
phenotype to the second recombination event in a
lineage—the formation of a double-crossover clone.
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generally applicable strategy which we call allele-coupled
exchange (ACE). The variant demonstrated using
pMTL-JH15, 16, 30 and 31 is particularly interesting
and broadly applicable, because providing the entire
coding sequence of a heterologous marker on the
plasmid means that any genomic locus with a promoter
can be a target for integration. Furthermore, using a
chromosomal promoter to direct expression of a heterol-
ogous gene of interest allows the gene to be cloned without
a promoter, precluding toxicity which might otherwise
result from over-expression in the cloning host. This
variant also allows speciﬁc selection of double-crossover
clones using only positively selectable markers, like
antibiotic-resistance genes, which are more easily applied
to diverse organisms than counter-selection markers.
Perhaps the most exciting implication of this work is the
potential to iteratively introduce large insertions (beyond
the size which could be delivered in a single step) in a
similar way to procedures available for organisms which
Figure 3. Multistep insertion of the chromosome of phage lambda into the chromosome of C. acetobutylicum.( A) Chromosome of phage lambda
showing restriction sites used to excise the three overlapping fragments. Yellow, 28kb XmaI-XmaI fragment L28; blue, 18kb NheI-AscI fragment
L18; green, 6.5kb XmaI-XhoI fragment L6.5; white, regions of overlap between fragments; cross-shaded deletion, 6kb region of L18 absent from
L12; coh, ligated cohesive ends. (B) Integration plasmids pMTL-JH16::L28, pMTL-JH30::L12 and pMTL-JH15::L6.5. The lambda sequences are
colored as in (A). Gray arrows e and p, inactive (non-expressed) ermB and pyrE, respectively; black, homology to thl locus; E, EcoRI sites; dashed
lines, EcoRI fragments (except those spanning the plasmid backbone); numeric labels, EcoRI fragment lengths in kilo base pair. (C) The thl locus of
C. acetobutylicum before and after 1, 2 and 3 insertions of lambda DNA. Elements are labeled as in (B). The ﬁrst recombination event at each step,
indicated, is directed by a long region of homology. A short region of homology mediates plasmid excision and simultaneously activates ermB or
pyrE in alternate steps, shown by red arrows e and p, respectively, by positioning them under the control of the chromosomal thl promoter.
(D) Southern blot of EcoRI digests of the plasmids and chromosomes shown in (B) and (C), using lambda DNA as probe. MW,
HindIII-digested lambda DNA molecular weight marker.
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structed all the plasmids necessary to undertake such
multi-step ACE strategies at each of the loci studied
here (Table 1). In our proof-of-principle experiment over
40 kb of lambda DNA was inserted into the chromosome
of C. acetobutylicum, which is the largest arbitrary
sequence integrated in any Clostridium by an order of
magnitude (27–29). After each successful transformation
of the lambda constructs, double-crossover clones were
obtained just as easily as in the earlier experiments using
the empty vectors. However, for both pMTL-JH16::L28
and pMTL-JH30::L12, several electroporation attempts
were required before transformant colonies were
observed. Apparently, inserts of this size substantially
decrease transformation frequency to a level that reduces
the practicality of the procedure. This observation suggests
that the size of inserts used in multistep strategies, at least
in C. acetobutylicum, should strike a balance between the
number of steps and the ease of each step. Inserts L28 and
L12 appear to be larger than the optimum.
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